# Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion

> **NCT07446647** · PHASE1 · RECRUITING · sponsor: **Jose Cancelas** · enrollment: 20 (estimated)

## Conditions studied

- Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused

## Interventions

- **BIOLOGICAL:** Biotinylated Red Blood Cells (BioRBC)
- **BIOLOGICAL:** Irradiated Biotinylated Red Blood Cells (Irradiated BioRBC)
- **BIOLOGICAL:** 51 Chromium Labeled Red Blood Cells (51Cr RBC)
- **BIOLOGICAL:** Technetium 99m Labeled Red Blood Cells (99mTc RBC)

## Key facts

- **NCT ID:** NCT07446647
- **Lead sponsor:** Jose Cancelas
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07446647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07446647, "Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07446647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*